Healthy Transitions in Late Stage Kidney Disease

NCT ID: NCT02085837

Last Updated: 2017-01-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

130 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-10-31

Study Completion Date

2016-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Improve health and outcome for people with late stage chronic kidney disease by providing patient centered nursing services in addition to a Nephrologist's routine patient care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Kidney Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy Transitions Group

* Additional nursing services will be provided to this group in addition to a usual care by Nephrologist.
* Daily weight measurement and monitoring
* Medication review
* Universal dietary education
* Focused advanced directive program
* Countdown to fistula program

Group Type EXPERIMENTAL

Education

Intervention Type OTHER

Additional education will be provided by nurses to improve communication and reduce fragmentation of care.

Daily weight measurement and monitoring

Intervention Type OTHER

Monitor weight to avoid problems related to hypervolemia.

Universal Dietary education

Intervention Type OTHER

To improve diet and health

Medication review

Intervention Type OTHER

Medication will be reviewed by nurses to detect any discrepancies to reduce medication error.

Focused advanced directive program

Intervention Type OTHER

Education will be provided to increase awareness and encourage patients to have advanced directive.

Countdown to fistula program

Intervention Type OTHER

To reduce the number of patients starting dialysis with catheter in place, comprehensive stepwise intervention will be provided by nurses to ensure arterio-venous (AV) fistula placement in all appropriate patients, with coordinated follow up and failure recovery processes.

Usual Care Group

Usual care by nephrologist. No additional nursing support services will be provide to this group.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Education

Additional education will be provided by nurses to improve communication and reduce fragmentation of care.

Intervention Type OTHER

Daily weight measurement and monitoring

Monitor weight to avoid problems related to hypervolemia.

Intervention Type OTHER

Universal Dietary education

To improve diet and health

Intervention Type OTHER

Medication review

Medication will be reviewed by nurses to detect any discrepancies to reduce medication error.

Intervention Type OTHER

Focused advanced directive program

Education will be provided to increase awareness and encourage patients to have advanced directive.

Intervention Type OTHER

Countdown to fistula program

To reduce the number of patients starting dialysis with catheter in place, comprehensive stepwise intervention will be provided by nurses to ensure arterio-venous (AV) fistula placement in all appropriate patients, with coordinated follow up and failure recovery processes.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Stage 4-5 Chronic Kidney Disease (CKD), defined as estimated glomerular filtration rate (eGFR) between 0-30 ml/minute
* 18 years of age or older

Exclusion Criteria

* Cognitive impairment that is clinically apparent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Northwell Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Steven Fishbane

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Steven Fishbane, MD

Role: PRINCIPAL_INVESTIGATOR

Northwell Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Division of Kidney diseases and Hypertension

Great Neck, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

13-033

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Kidney Health: Eat Well, Live Well
NCT05970341 RECRUITING NA